Sunday, July 21, 2019

Fetal Stem Cell Therapy And Stem Cells - The Latest Information video.

Fetal Stem Cell Therapy And Stem Cells - The Latest Information The Real Truth About Health
Fetal Stem Cell Therapy And Stem Cells - The Latest Information by Eric Merola Eric Merola is an internationally award-winning documentary filmmaker. For the last decade Eric has directed and produced four documentaries exploring disruptive scientific technologies in the space of medical research. Merola’s first documentary, Burzynski: Cancer Is Serious Business (2010) was an international success seen by tens of millions of people worldwide. This project was also presented on Netflix, PBS, The Documentary Channel, and various international television outlets. The positive reception of the Burzynski story led Merola to produce its sequel, Burzynski: Cancer Is Serious Business, Part II (2013). Merola’s third documentary, Second Opinion: Laetrile At Sloan-Kettering (2014) tells the story of Ralph W. Moss, PhD, who blew the whistle on the successful laetrile studies conducted for 5 years at Sloan-Kettering Cancer Center in New York City in the 1970s. Today, Eric Merola is most passionate about “fetal stem cell therapy”, where he has spent the last 4 years researching and releasing his most recent documentary, The God Cells: A Fetal Stem Cell Journey (2017-present). Merola continues to follow new patients who seek fetal stem cell treatment and share their stories. Merola feels that “fetal stem cells” could be the most disruptive technology he’s discovered in the medical research space, potentially replacing nearly every pharmaceutical medication on the market. Connect with The Real Truth About Health https://ift.tt/2JY2men https://ift.tt/2mENbgs https://ift.tt/2Fwh1xd https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO's. Fighting to stop climate change and extinction. Please support the sponsors of our conference https://ift.tt/2mK7jOw


View on YouTube

No comments:

Post a Comment